12/2
08:42 am
adgm
Adagio Medical (NASDAQ:ADGM) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $4.00 price target on the stock.
High
Report
Adagio Medical (NASDAQ:ADGM) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $4.00 price target on the stock.
11/26
02:00 pm
adgm
Adagio Medical (NASDAQ:ADGM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Adagio Medical (NASDAQ:ADGM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
04:05 pm
adgm
Adagio Medical Reports Third Quarter 2025 Results
Medium
Report
Adagio Medical Reports Third Quarter 2025 Results
11/5
08:00 am
adgm
Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
10/30
12:24 pm
adgm
Adagio Medical (NASDAQ:ADGM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Adagio Medical (NASDAQ:ADGM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/20
08:00 am
adgm
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
Medium
Report
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
10/15
08:00 am
adgm
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
High
Report
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
10/10
03:40 pm
adgm
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium
High
Report
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium
10/3
02:37 pm
adgm
Adagio Medical (NASDAQ:ADGM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Adagio Medical (NASDAQ:ADGM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
08:00 am
adgm
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
Low
Report
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
9/18
08:00 am
adgm
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
Medium
Report
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
9/8
08:00 am
adgm
Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities
High
Report
Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities